Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part
Google once said it wanted to declare war against disease. When it said so, 23andMe, invested by it has serviced 200,000 people; iPierian (mainly for stem cells), invested by it was facing a big moment. Thus we don’t need to feel surprised when we hear about that Google is going to set up a new company—Calico to solve health related problems.
By reviewing we can find that Google Ventures has also involved in many health-care companies/institutions, for example, Foundation Medcine, DNAnuxus, Wingu, Flatiron Health and Predilytics.
In this field, it seems Google is finding its road though the fact that in 2008, Google launched Google Health for online medical record service and closed the service after three years.
Future health-care will be highly “personalized medical care”, which links to data management, accurate diagnosis, Gene mapping and cellular therapy. Google might be stranger to medical part, but it is expert to IT system and data collection.
“When you run a business, market is certainly important, but social responsibility equally matters”.—said by the president of Creative BioMart that delicates to offer recombinant proteins, antibodies, industrial enzymes etc.
After the investment of medical part, if a bit of more imagination and ambition, will Google “embark on” bio-pharmaceuticals? It seems nothing is impossible…